RAC 0.97% $1.54 race oncology ltd

Ann: Race Strategic Update August 2023, page-281

  1. 1,244 Posts.
    lightbulb Created with Sketch. 2461
    I would just stop asking Daniel. There’s a reason why he’s now on the outside. It’s very clear there’s a bias in investing based on previous success or market knowledge (in Perth & in Sydney) that he still feels qualified to make these judgements

    Its often at massive odds with others in the market and often the only example of sticking up for shareholders draws back to an example of where he benefited.

    For every example I point to for this company being successful, being the drug, the BP
    interested , the prior history, current experienced management, the CURRENT strategy etc

    Ask yourself where the language is from Davisite?
    “If it wasn’t for me it would be lost forever” I found cardio protection etc” I have looked after shareholders etc.

    Im frankly sick of it. And I say that as a 3-4 year shareholder. Not worried about the SP but more getting pissed off at the divide certain ego’s are causing when a company is trying to progress things and right wrongs that prior decisions have created.

    It’s unbelievably clear to any sophisticated investor the first sense of blame or divide in a company, stay away.

    Unfortunately an ego (with good intentions
    ) has in my view been the kicker to a recent downfall.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.